Loading clinical trials...
Loading clinical trials...
A Randomized, Double Blind, Placebo-Controlled Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa
Conditions
Interventions
placebo
darbepoetin alfa
Start Date
December 1, 2002
Primary Completion Date
January 1, 2007
Completion Date
April 1, 2007
Last Updated
August 8, 2008
NCT07190248
NCT06305754
NCT05692635
NCT07485114
NCT06066138
NCT07100080
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions